Recent Updates
Recently added Catalysts
NSPR Positive Sentiment Score: 75/100

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

Key Takeaway: InspireMD, Inc. (Nasdaq: NSPR) has announced its upcoming presentation at the 24th Annual Needham Virtual Healthcare Conference scheduled for April 9, 2025. The presentation will showcase the company's CGuard™ Prime carotid stent system aimed at treating carotid artery disease and preventing stroke. A live audio webcast of the event will be available for 90 days on InspireMD's website. The company emphasizes its focus on using proprietary technology to enhance patient outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • InspireMD is presenting at a prestigious healthcare conference.
  • The CGuard™ Prime carotid stent system is innovative and aimed at preventing stroke.
  • The company's technologies are positioned to become industry standards with promising outcomes.

Full Press Release Details

MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 8:00AM Eastern Time / 5:00AM Pacific Time.
A live audio webcast and replay of the presentation may be accessed for 90 days on the “News & Events” section of the company’s website at: https://www.inspiremd.com/en/events/
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Chief Financial Officer

Frequently Asked Questions

What is InspireMD's primary focus?

InspireMD develops the CGuard™ Prime carotid stent system for carotid artery disease.

When will InspireMD present at the Needham Virtual Healthcare Conference?

InspireMD will present on April 9, 2025, at 8:00 AM Eastern Time.

How can I access InspireMD's presentation?

The presentation will be available via audio webcast on the company’s website.

What technology does InspireMD use for its products?

InspireMD utilizes its proprietary MicroNet® technology for carotid stenting.

Where can I find more information about InspireMD?

Visit www.inspiremd.com for more details and investor updates.

Last updated: Mar 26, 2025